目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T7399 | Wnt/beta-catenin | ||
LF3 是一种典型 Wnt 信号传导的特异性抑制剂,通过破坏 β-catenin 和 TCF4 之间的相互作用(IC50 < 2 μM) | |||
T9182 | Others Wnt/beta-catenin | ||
NRX-252262 是 β-Catenin 与同源 E3 ligaseSCFβ-TrCP 的相互作用增强剂,能够诱导 β-catenin 的降解,其 EC50=3.8 nM。 | |||
T1971 | Wnt/beta-catenin | ||
WAY262611是一种 Wnt/β- 联蛋白激动剂,也是一种Dkk1的抑制剂。它能够增加骨形成速率,在 TCF- 荧光素酶测定实验中的EC50=0.63 μM。 | |||
T15137 | Wnt/beta-catenin AMPK | ||
DK419 是一种具有口服活性的 Wnt/β-catenin 信号通路抑制剂,IC50 为 0.19 μM。 DK419 降低 Axin2、β-catenin、c-Myc、Cyclin D1 和 Survivin 的蛋白质水平。它还诱导 pAMPK 的产生。 | |||
T15677 | Wnt/beta-catenin | ||
KY1220 通过靶向 Wnt/β-连环蛋白通路,使 β-连环蛋白和 Ras 不稳定。 它在 HEK293 报告细胞中的 IC50 为 2.1 μM。 | |||
T6989 | Wnt/beta-catenin | ||
SKL2001 是一种Wnt/β-catenin 信号通路的激动剂,具有抗肿瘤作用。它能够破坏 Axin/β-catenin 相互作用,稳定细胞内 β-catenin。 | |||
T9151 | Wnt/beta-catenin | ||
Teplinovivint 是 wnt/β-catenin 信号通路抑制剂。它具有抗炎作用,对用于肌腱病具有潜在的研究价值。 | |||
T12537 | Wnt/beta-catenin | ||
β-catenin/CBP-IN-1 is a potent and selective inhibitor of CBP/β-catenin | |||
T5642 | Wnt/beta-catenin | ||
Tegatrabetan (BC2059) 是β-Catenin 拮抗剂,能够破坏 β-catenin 与转导素 β 样蛋白 1 (TBL1) 结合。 | |||
T3062 | PARP Wnt/beta-catenin | ||
WIKI4 是tankyrase 有效抑制剂,其对TNKS2的IC50值为 26 nM。它有效抑制Wnt/β-catenin 信号传导,其EC50值为 75 nM。它通过抑制TNKS2的酶活性来介导其对Wnt/β-catenin 信号传导的影响。它对 SCLC 细胞具有细胞毒性,其IC50值为 0.02 μM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-02205 | Beta-Catenin Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells | ||
Beta-Catenin Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 113 kDa and the accession number is P35222-1.
|
|||||
TMPY-02985 | Beta-Catenin Protein, Mouse, Recombinant (His & GST) | Mouse | Baculovirus Insect Cells | ||
Beta-Catenin Protein, Mouse, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 113 kDa and the accession number is Q02248.
|
|||||
TMPK-00744 | LRP-6 Protein, Human, Recombinant (mFc) | Human | HEK293 Cells | ||
Dickkopf-related protein 1 (DKK-1), a ligand for the WNT coreceptors low-density lipoprotein receptor-related proteins 5 and 6 (LRP-5 and LRP-6) and an inhibitor of WNT/β-catenin signaling, effectively inhibits pericyte activation, detachment, and transition to myofibroblasts in vivo in response to kidney injury, resulting in attenuated fibrogenesis, capillary rarefaction, and inflammation.LRP-6 interacts closely with PDGF receptor β and TGF-β receptor 1 at the cell membrane, suggesting that it may have roles in pathways other than WNT/β-catenin.
|
|||||
TMPK-01001 | RNF43 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells | ||
RNF43 (E3 ubiquitin-protein ligase RNF43 or RING-type E3 ubiquitin transferase RNF43) functions as a tumor suppressor, by exerting a predominant negative feedback mechanism in the Wnt/β-catenin signaling pathway. RNF43 inhibits Wnt/beta-catenin signaling by ubiquitinating Frizzled receptor and targeting it to the lysosomal pathway for degradation.
|
|||||
TMPK-00157 | DKK1 C terminal Domain Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells | ||
Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes. DKK1 C terminal Domain Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-hFc-Avi tag. The predicted molecular weight is 38.69 kDa and the accession number is O94907.
|
|||||
TMPK-00155 | DKK1 C terminal Domain Protein, Human, Recombinant (hFc & Avi) | Human | HEK293 Cells | ||
Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes. DKK1 C terminal Domain Protein, Human, Recombinant (hFc & Avi) is expressed in HEK293 mammalian cells with C-hFc-Avi tag. The predicted molecular weight is 38.69 kDa and the accession number is O94907.
|
|||||
TMPK-00743 | LGR-5 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
G protein-coupled receptor 5 (LGR5), known as a stem cell marker for colon cancer and gastric cancer, can serve as a novel GSC marker involved in EMT and a therapeutic target in glioma.LGR5 is a new functional GSC marker and prognostic indicator that can promote EMT by activating the Wnt/β-catenin pathway and would thus be a novel therapeutic target for glioma.
|
|||||
TMPK-00156 | DKK1 N terminal Domain Protein, Human, Recombinant (hFc & Avi) | Human | HEK293 Cells | ||
Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes. DKK1 N terminal Domain Protein, Human, Recombinant (hFc & Avi) is expressed in HEK293 mammalian cells with C-hFc-Avi tag. The predicted molecular weight is 40.25 kDa and the accession number is O94907.
|
|||||
TMPK-00158 | DKK1 N terminal Domain Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells | ||
Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes. DKK1 N terminal Domain Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-hFc-Avi tag. The predicted molecular weight is 40.25 kDa and the accession number is O94907.
|
|||||
TMPK-01304 | Kremen-2 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells | ||
Kremen2 (Krm2) plays an important role in embryonic development, bone formation, and tumorigenesis as a crucial regulator of classical Wnt/β-catenin signaling pathway. Compared to para-cancerous tissues, Krm2 was significantly up-regulated in gastric cancer tissues and was positively correlated with the pathological grade of gastric cancer patients. Krm2 can be a potent candidate for designing of targeted therapy. Kremen-2 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 37.04 kDa and the accession number is XP_005591068.2.
|
|||||
TMPK-00925 | Noggin/NOG Protein, Mouse, Recombinant | Mouse | HEK293 Cells | ||
Noggin is an antagonist of bone morphogenetic proteins (BMP), being indispensable for certain developmental events.Noggin expression positively correlated with EGFR expression in both GC cell line models and The Cancer Genome Atlas human GC cohort. Targeting EGFR and its downstream pathways diminished cell proliferation which was promoted by Noggin. Noggin promotes the proliferation of GC cells by upregulating EGFR and enhancing a vicious circle formed by β‑catenin, EGFR, ERK and Akt. Noggin/NOG Protein, Mouse, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 23.07 kDa and the accession number is P97466.
|
|||||
TMPK-01093 | Kremen-2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells | ||
Kremen2 (Krm2) plays an important role in embryonic development, bone formation, and tumorigenesis as a crucial regulator of classical Wnt/β-catenin signaling pathway. Compared to para-cancerous tissues, Krm2 was significantly up-regulated in gastric cancer tissues and was positively correlated with the pathological grade of gastric cancer patients. Krm2 can be a potent candidate for designing of targeted therapy. Kremen-2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 37.4 kDa and the accession number is Q8K1S7.
|
|||||
TMPK-01106 | Kremen-2 Protein, Human, Recombinant (His) | Human | HEK293 Cells | ||
Kremen2 (Krm2) plays an important role in embryonic development, bone formation, and tumorigenesis as a crucial regulator of classical Wnt/β-catenin signaling pathway. Compared to para-cancerous tissues, Krm2 was significantly up-regulated in gastric cancer tissues and was positively correlated with the pathological grade of gastric cancer patients. Krm2 can be a potent candidate for designing of targeted therapy. Kremen-2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 37.1 kDa and the accession number is Q8NCW0-1.
|
|||||
TMPK-00926 | Noggin/NOG Protein, Mouse, Recombinant (His & Flag) | Mouse | HEK293 Cells | ||
Noggin is an antagonist of bone morphogenetic proteins (BMP), being indispensable for certain developmental events.Noggin expression positively correlated with EGFR expression in both GC cell line models and The Cancer Genome Atlas human GC cohort. Targeting EGFR and its downstream pathways diminished cell proliferation which was promoted by Noggin. Noggin promotes the proliferation of GC cells by upregulating EGFR and enhancing a vicious circle formed by β‑catenin, EGFR, ERK and Akt. Noggin/NOG Protein, Mouse, Recombinant (His & Flag) is expressed in HEK293 mammalian cells with N-His-Flag tag. The predicted molecular weight is 25.16 kDa and the accession number is P97466.
|